Top Markets
Coin of the day
Vaxart, Inc. Vaxart, Inc.

Vaxart, Inc.

VXRT
Rangering i aksjer #20724
Vaxart, Inc. operates as a biotechnology firm currently in the clinical... Vaxart, Inc. operates as a biotechnology firm currently in the clinical development phase, concentrating its efforts on identifying and advancing novel oral recombinant protein vaccines. The company leverages its unique proprietary platform for delivering these oral vaccine solutions. Its diverse pipeline showcases several promising candidates: An oral tablet vaccine targeting norovirus, which is presently undergoing Phase Ib clinical assessment for both GI.1 and GII.4 strains. A seasonal influenza vaccine, now in Phase II clinical studies, designed to address H1 influenza infections. A vaccine candidate against respiratory syncytial virus (RSV). A coronavirus vaccine, also advancing through Phase II clinical trials for SARS-CoV-2. Beyond infectious diseases, Vaxart is also engaged in formulating therapeutic vaccines aimed at treating cervical cancer and dysplasia associated with human papillomavirus. The company's main operations are situated in South San Francisco, California.
Aksjekurs
$0.5106
Markedsverdi
$123.59M
Endring (1 dag)
-1.81%
Endring (1 år)
45.89%
Land
US
Handel Vaxart, Inc. (VXRT)

Kategori

Historikk for aksjesplitt for Vaxart, Inc. (VXRT)
Aksjen Vaxart, Inc. (symbol: VXRT) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 24, 2026.
Én VXRT-aksje kjøpt før Aug 24, 2026 tilsvarer i dag 0 VXRT-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH